Associated Papers
The genetic landscape of major drug metabolizing cytochrome P450 genes-an updated analysis of population-scale sequencing data.
Zhou Y et al.
The Pharmacogenomics Journal, 2022
36068297 (PubMed )
Supplement: 41397_2022_288_MOESM4_ESM.xlsx › Sheet1
Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions.
Backman JT et al.
Pharmacological Reviews, 2016
Pharmacokinetics of paclitaxel in ovarian cancer patients and genetic polymorphisms of CYP2C8, CYP3A4, and MDR1.
Nakajima M et al.
Journal of Clinical Pharmacology, 2005
Cytochrome P450 2C8: substrates, inhibitors, pharmacogenetics, and clinical relevance.
Totah RA et al.
Clinical Pharmacology and Therapeutics, 2005
A frameshift variant of CYP2C8 was identified in a patient who suffered from rhabdomyolysis after administration of cerivastatin.
Ishikawa C et al.
Journal of Human Genetics, 2004
Genetic polymorphisms of CYP2C8 in Japanese population.
Nakajima M et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2003
Select a paper to view details